Biotechnology
Company Overview of Valentis Inc.
Company Overview
As of July 13, 2007, Valentis Inc. was acquired by Urigen N.A., Inc., in a reverse merger transaction. Valentis, Inc. does not have significant operations. Previously, the company was engaged in the development of products for peripheral artery disease. Valentis, Inc. was founded in 1992 and is headquartered in Burlingame, California.
533 Airport Boulevard
Suite 400
Burlingame, CA 94010
United States
Founded in 1992
Phone:
650-697-1900
Fax:
650-652-1990
Key Executives for Valentis Inc.
Valentis Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
| Company Name | Region |
| Abbott Chemicals, Inc. | United States |
| BioSeek, Inc. | United States |
| LifeSpan BioSciences, Inc. | United States |
| Wockhardt USA, Inc. | United States |
| Cirrus Pharmaceuticals, Inc. | United States |
Recent Private Companies Transactions
| Type Date |
Target | |
| No transactions available in the past 12 months. | ||
Most Searched Private Companies
| Company Name | Geographic Region |
| Bertelsmann AG | Europe |
| Lawyers Committee for Civil Rights Under Law | United States |
| NYC2012, Inc. | United States |
| Rush University | United States |
| Citizens Budget Commission | United States |
Post a JobJobs
- Adelphi, MD | University of Maryland University CollegePosted: Jun 12
- Milwaukee, WI | Robert W. BairdPosted: Apr 19
- Dallas, TX | Santa Cruz BiotechnologyPosted: Jun 11
- Greenfield, IN | CovancePosted: May 31
Sponsored Financial Commentaries
Sponsored Links
To contact Valentis Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
